WEAV

WEAVE COMMUNICATIONS INC

Healthcare | Small Cap

-$0.10

EPS Forecast

$65.01

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-20

Weave’s Q1 2026: A Measured Loom of Growth as AI Tools Tighten the Weave

Weave Communications, ticker WEAV, reported first-quarter 2026 results with a healthy revenue uptick and margins that edge closer to profitability on a non-GAAP basis. EPS and revenue forecast readers will be watching closely for any shift in trajectory as the AI toolkit expands across the platform.

Executive snapshot

The company posted total revenue of $65.5 million for the quarter, up 17.4% year over year, underscoring sustained demand for its AI-powered patient engagement and payments platform. On the margin line, GAAP gross margin stood at 72.6%, with Non-GAAP gross margin at 73.2%, signaling a modest tilt toward profitability on a non-GAAP basis as the mix and operating leverage evolve.

From an earnings-per-share perspective, GAAP net loss came in at $5.8 million, or $0.07 per share, while Non-GAAP net income was $2.8 million, or $0.04 per share. GAAP loss from operations was $6.0 million, versus $9.3 million in the year-ago quarter; Non-GAAP operating income reached $2.5 million (versus zero in the prior-year period).

The numbers in plain English

  • Revenue: $65.5 million, up 17.4% year over year.
  • GAAP gross margin: 72.6%.
  • Non-GAAP gross margin: 73.2%.
  • GAAP loss from operations: $6.0 million.
  • Non-GAAP income from operations: $2.5 million.
  • GAAP net loss per share (EPS): $0.07.
  • Non-GAAP net income per share (EPS): $0.04.

Management commentary

“Weave delivered another excellent quarter, with revenue growth accelerating to 17.4% year-over-year and the most customer location additions in a single quarter in our history. We also drove significant year-over-year improvements in profitability. This success is a clear result of our disciplined business operations,” said Brett White, CEO of Weave.

“Over 50% of customer locations are currently using the AI tools embedded in our platform. The upcoming release of our omnichannel AI receptionist, supporting both voice- and text-based conversations, fundamentally strengthens our future role as a proactive, agentic, always-on teammate that manages the complete patient journey.”

Recent business highlights

  • Named to G2’s 2026 Best Software Awards, ranking #2 on the Best Healthcare Software Products list with broad reach among buyers.
  • Weave’s Private Communications feature enables segregated practitioner inboxes for sensitive patient communications.
  • Ongoing enhancements to Weave Payments platform include bulk collections for Dentrix Enterprise, Fuse, and Eaglesoft, plus new payment writebacks for Athena, NexTech Health, and NT Practice+.

Outlook for Q2 and the full year 2026

The company laid out expectations for the three months ending June 30, 2026, and the full year ending December 31, 2026, though the excerpt here does not publish the full numerical guidance. Still, the emphasis is clear: continued revenue growth, margin discipline, and a path toward higher operating leverage as AI-enabled capabilities scale. Investors will likely compare the reported EPS (both GAAP and Non-GAAP) and the revenue forecast against EPS consensus estimates and any implied earnings surprise, watching for meaningful deviations that might alter the stock’s multiple.

Implications for WEAV and sector peers

Weave’s progress sits at an intersection of vertical SaaS growth and healthcare digital transformation. The dual-track margin improvement—non-GAAP gross margin improving while the company monetizes AI features—suggests that profitability potential is not merely a function of top-line expansion but of productivity gains from platform-scale, data-network effects, and cross-sell of adjacent modules like Private Communications and AI-enabled receptionist tools.

For peers in the healthcare IT and vertical SaaS space, the key takeaway is less about a flashy EPS beat and more about how AI-enabled patient engagement tools translate into higher wallet share per practice and improved unit economics. If Weave can maintain positive operating leverage while expanding its active locations, the story could reset valuations for platforms that blend patient experience with payments in a single ecosystem.

Risk factors and market context

Guidance for Q2 and 2026 will be weighed against secular tailwinds in healthcare digitization, competition from larger platform players, and the cost of continuing investment in AI features. The balance between revenue growth and EPS discipline remains the central question for investors—whether the path to profitability is via faster top-line growth, gross margin expansion, or a combination of both—and how that translates into a plausible earnings surprise risk or mitigation relative to consensus expectations.

Bottom line

Weave’s Q1 2026 results show a company expanding its AI toolkit while creeping toward profitability on a non-GAAP basis. The revenue trajectory remains solid, and the margin lift hints at improving efficiency as platform usage grows. For WEAV and its sector peers, the real test is whether these trends sustain into the back half of 2026 and how the company balances investment in AI with the discipline investors expect from earnings per share and the revenue forecast. The loom is spinning; whether the fabric shows resilience or redundancy will depend on execution and the pace of adoption across healthcare practices.